alpha -1,4-GLUCAN LYASE AND ITS USE IN THE PRODUCTION OF 1,5-ANHYDROFRUCTOSE

Abstract: An enzyme isolatable from algae is described. Also, a method of preparing the sugar 1,5-D-anhydrofructose is described. The method comprises treating an alpha -1,4-glucan with an alpha -1,4-glucan lyase wherein the enzyme is used in substantially pure form. In a preferred embodiment, if the glucan contains links other than and in addition to the alpha -1,4-links, the alpha -1,4-glucan lyase is used in conjunction with a suitable reagent that can break the other links.

Description: -1 ,4-gl ucaπ lyase and Its use 1n the production of 1 , 5-anhydrofructose The present invention relates to an enzyme α-l,4-glucan lyase ("GL") and, in particular, its use to prepare 1,5-D-anhydrofructose ("AF") from substrates based on α-l,4-glucan. The present invention also relates to the use of a sugar, in particular 1,5-D- anhydrofructose ("AF") prepared by the method of the present invention, as an anti- oxidant, in particular as an anti-oxidant for food stuffs and beverages. The present invention relates to the use of 1,5-D-anhydrofructose ("AF"), in particular AF prepared by the method of the present invention, as a sweetener, in particular as a sweetener for foodstuffs and beverages, preferably human foodstuffs and beverages. FR-A-2617502 and Baute et al in Phytoche istry [1988] vol. 27 No.ll pp3401-3403 report on the production of AF in Morchella vulgaris by an apparent enzymatic reaction. The yield of production of AF is quite low. Despite a reference to a possible enzymatic reaction, neither of these two documents presents any amino acid sequence data for any enzyme let alone any nucleotide sequence information. These documents say that AF can be a precursor for the preparation of the antibiotic pyronc microthecin. Yu et al in Biochimica et Biophysica Acta [1993] vol 1156 pp313-320 report on the preparation of GL from red seaweed and its use to degrade α-l,4-glucan to produce AF. The yield of production of AF is quite low. Despite a reference to the enzyme GL this document does not present any amino acid sequence data for that enzyme let alone any nucleotide sequence information coding for the same. A typical α-l,4-glucan based substrate is starch. Today, starches have found wide uses in industry mainly because they are cheap raw materials. Starch degrading enzymes can be grouped into various categories. The starch hydrolases produce glucose or glucose-oligomers. A second group of starch degrading enzymes are phosphorylases that produce glucose- 1 -phosphate from starch in the presence of inorganic phosphate. AF has also been chemically synthesised - see the work of Lichtenthaler in Tetrahedron Letters Vol 21 pp 1429-1432. However, this chemical synthesis involves a large number of steps and does not yield large quantities of AF. The chemical synthetic route for producing AF is therefore very expensive. There is therefore a need for a process that can prepare AF in a cheap and easy manner and also in a way that enables large quantities of AF to be made. Furthermore, anti-oxidants are typically used to prevent oxygen having any deleterious effect on a substance such as a foodstuff. Two commonly used anti-oxidants arc GRINDOX 142 and GRINDOX 1029. These anti-oxidants contain many components and are quite expensive to make. There is therefore a need to have a simpler and cheaper form of anti-oxidant. Furthermore, sweeteners are often used in the preparation of foodstuffs and beverages. However, many sweeteners are expensive and complex to prepare. There is therefore a need to have a simpler and cheaper form of sweetener. According to a first aspect of the present invention there is provided an enzyme comprising at least any one of the amino acid sequences shown as SEQ. ID. No.s 3-4, or any variant thereof. According to a second aspect of the present invention there is provided a nucleotide sequence coding for the enzyme of the first aspect of the present invention. Preferably the nucleotide sequence is a DNA sequence. According to a third aspect of the present invention there is provided a nucleotide sequence comprising a sequence that is the same as, or is complementary to, or has substantial homology with, or contains any suitable codon substitutions for any of those of SEQ. ID. No. 1 or SEQ. ID. No. 2. According to a fourth aspect of the present invention there is provided a method of preparing the sugar 1,5-D-anhydrofructose comprising treating an α-l,4-glucan with the enzyme α-l,4-glucan lyase, characterised in that enzyme is used in substantially pure form and wherein the enzyme is isolated from algae alone. According to a fifth aspect of the present invention there is provided a method of preparing the sugar 1,5-D-anhydrofructose comprising treating an α-l,4-glucan with the enzyme α-l,4-glucan lyase characterised in that enzyme comprises at least any one of the amino acid sequences shown as SEQ. ID. No.s 3 - 4, or any variant thereof. According to a sixth aspect of the present invention there is provided the sugar 1,5- D-anhydrofructose when prepared by the method of the present invention. According to a seventh aspect of the present invention there is provided the use of a reagent that can increase the hydrophobicity of the reaction medium to increase the stability and activity of the GL enzyme. According to an eighth aspect of the present invention there is provided the use of AF prepared by the method of the present invention as an anti-oxidant. According to a ninth aspect of the present invention there is provided the use of AF prepared by the method of the present invention as a sweetener. Preferably the enzyme is obtainable from algae, preferably it is obtainable from Gracilariopsis lemaneiformis. Preferably the enzyme comprises at least any one of the amino acid sequences shown as SEQ. ID. No.s 3 - 4, or any variant thereof. Preferably the enzyme is obtained from the expression of a nucleotide sequence coding for the enzyme. Preferably the nucleotide sequence is a DNA sequence. Preferably the DNA sequence comprises a sequence that is the same as, or is complementary to, or has substantial homology with, or contains any suitable codon substitutions for any of those of SEQ. ID. No. 1 or SEQ. ID. No. 2. Preferably if the glucan contains links other than and in addition to the α-1,4- links the α-l,4-glucan lyase is used in conjunction with a suitable reagent that can break the other links. Preferably the glucan is starch. Preferably a glucanohydrolase is used in conjunction with the -l,4-glucan lyase. Preferably the starch is used in high concentration - such as up to about 25% solution. Preferably the hydrolase is at least one of pullanase or isoamylase. Preferably the α-l,4-glucan lyase is bound to a support or, more preferably, is in a dissolved form. Preferably the enzyme is isolated and/or further purified from algae alone using a gel that is not degraded by the enzyme. Preferably the gel is based on dextrin or derivatives thereof, preferably the gel is a cyclodextrin - more preferably β-cyclodextrin. Preferably the substrate is treated with the enzyme in the presence of a buffer. Alternatively, preferably the substrate is treated with the enzyme in the presence of at least substantially pure water. Preferably the substrate is treated with the enzyme in the absence of a co-factor. Preferably the enzyme is used in combination with amylopectin or dextrin. The terms "variant" or "homologue" include any substitution of, variation of, modification of, replacement of, deletion of or addition of one (or more) nucleic acid or amino acid from or to the respective sequence providing the resultant sequence has the respective ability to code for or act as an enzyme according to the present invention. In particular, the term "homologue" covers homology with respect to structure and/or function providing the resultant nucleotide sequence has the ability to act as a promoter. With respect to sequence homology, preferably there is more than 80% homology, more preferably at least 85% homology, more preferably at least 90% homology, even more preferably at least 95% homology, more preferably at least 98% homology. Thus, the expression "substantial homology" covers homology with respect to structure and/or nucleotide components and/or biological activity. The expression "contains any suitable codon substitutions" covers any codon replacement or substitution with another codon coding for the same amino acid or any addition or removal thereof providing the resultant enzyme has lyase activity. In other words, the present invention also covers a modified DNA sequence in which at least one nucleotide has been deleted, substituted or modified or in which at least one additional nucleotide has been inserted so as to encode a polypeptide having the activity of a glucan lyase, preferably having an increased lyase activity. AF prepared by the present method was confirmed and characterised by 13 C NMR. One of key advantages of the present method is that the sugar 1,5-D-anhydrofructose can be prepared in much larger quantities than before and by a method that is relatively easier and cheaper than the known processes. For example the sugar can now be prepared in amounts of for example greater than lOOg - such as 500g - compared to the prior art methods when only much smaller amounts were and could be produced - such as micro gram amounts. Typical reactions that can be catalyzed by GL can be summarised as follows: 1). Amylopectin ► AF + limit dextrin 2). Amylose ► AF + limit dextrin 3). Dextrin ► AF + glucose In reaction 1), the ratio of the two products depend on the structure of amylopectin or the distribution of α-l,6-glucosidic linkages in the amylopectin molecules. In reaction 2) and 3), the ratio of the products depends on the degree of polymerisation (DP) number of the substrate. In reaction 3 the ratio between AF and glucose depends upon the DP. For example if the dextrin contains 10 glucose units the ratio AF: glucose would be 9:1. Another advantage of the present invention is that glucans that contain links other than α-1,4- links can be substantially degraded - whereas before only partial degradation was achieved. The substantial degradation of the 1,5-D-anhydrofructose precursor is one of the factors leading to the increased yields of 1,5-D-anhydrofructose. Another advantage is that AF is a naturally occurring substance and therefore it has a potential for human purposes. For example, it can be converted to the antibiotic microthecin by AF dehydrase. Antibiotics are known for their uses in food bio- preservation, which is an important area in food technology. However, to date, the preparation of AF and also microthecin has had a number of disadvantages. For example, only small quantities could be produced. Also, the process was costly. The present invention overcomes these problems by providing a larger production of and much cheaper production of AF and so also other products such as microthecin. In this regard, it is possible to prepare gram to kilogram amounts of AF. A further advanatge is that the lyase is stable for at least one year at 4°C and can be lyophilized without loss of activity. Another advantage is that the lyase produces AF directly from starches and does not need the presence of any co-factors. Another advantage is that the enzyme can be used in pure water. This result is very surprising. Based on the simple properties of the present lyase, one can expect that the production cost of AF will be comparable to that of glucose. This is especially advantageous that the present lyase does not necessarily require the presence of any co-factors which are generally very expensive. In general α-l,4-glucans can be used as substrate for the enzyme. As a preferred substrate, starch is used. In a preferred process, soluble or gelatinized starch or starch hydrolysate are used. The starch hydrolysates can be prepared either chemically or enzymatically. If an enzyme is used for the partial starch degradation the enzyme can either be added before the addition of the lyase or any other additional starch degrading reagent (such as the enzyme glucanohydrolase) which may be added simultaneously. The lyase will convert the glucan to AF. The enzyme will attack the substrate from the non reducing end and leave only the reducing sugar unconverted. The residual glucose can be removed by known methods some of which have been described here. Using the reaction described here pure AF can be produced and also in large amounts. Thus, in one embodiment, the -l,4-glucan lyase is purified from algae - such as Gracilariopsis lemaneiformis - by affinity chromatography on ?-cyclodextrin Sepharose, ion exchange chromatography on Mono Q HR 5/5 and gel filtration on Superose 12 columns. The purified enzyme produces 1,5-anhydro-D-fructose from α-l,4-glucans. The enzymes of the present invention convert amylose and amylopectin to 1,5- anhydrofructose. Among the maltosaccharides tested, we found that the lyase showed low activity towards maltose, and lower activity to maltotriose and maltoheptaose with the highest activity to maltotetraose and maltopentaose. The enzyme showed no substrate inhibition up to a concentration 10 mg ml "1 among these maltosaccharides. The enzymes from the preferred source have been sequenced and the amino acid sequences are presented later. Also presented later are the DNA sequences coding for the enzymes. The present invention therefore describes a new starch degrading enzyme - namely a new α-l,4-glucan lyase. This is an enzyme that has been purified and characterized for the first time. As mentioned above, the present invention also relates to some specific uses of AF. In particular, the present invention relates to the use of 1,5-D-anhydrofructose ("AF"), as an anti-oxidant, in particular as an anti-oxidant for food stuffs and beverages. Therefore according to the present invention there is provided the use of 1,5-D- anhydrofructose (AF) as an anti-oxidant. Preferably AF is or is used in an edible substance. Preferably AF is used in or as a foodstuff or beverage. Preferably, AF is used in combination with another anti-oxidant. Preferably the AF is prepared by the method according to the present invention. The main advantages of using AF as an anti-oxidant are that it is a natural product, it is likely that it is non-metabolisable at least for humans, it is easy to manufacture, it is water-soluble, and it is generally non-toxic. A preferred embodiment the present invention therefore relates to the enzymatic preparation of pure AF which can be used as an attractive water soluble antioxidant for food and non-food purposes. Examples are given below for the use of AF as an antioxidant in food formulations. Experiments showed that the AF is comparable with known high quality commercial available food antioxidants. Non-food examples include use in polymer chemistry as oxygen scavengers during the synthesis of polymers. Also, AF could be used for the synthesis of bio-degradable plastic. Experiments have shown that AF can be an efficient reducing agent (antioxidant), as it can easily reduce 3,5-dinitrosalicylic acid to 3-amino-5-nitrosalicylic acid. AF is a naturally occurring substance and therefore it has a tremendous potential for use as an acceptable antioxidant. AF can also be converted into the antibiotic microthecin by AF dehydrase. Antibiotics are known for their uses in food biopreservation, an important area in food biotechnology. In another aspect, the present invention also relates to the use of 1,5-D- anhydrofructose as a sweetener, in particular as a sweetener for foodstuffs and beverages, preferably human foodstuffs and beverages. Thus according to this aspect of the present invention there is provided the use of 1,5- D-anhydrofructose as a sweetener. Preferably the AF is used as or in a human foodstuff or beverage. The AF may be used in any desired amount such as a 5% solution or lOOmg/kg to 500 mg/kg. The advantages of using AF as a sweetener are that it is a natural product, it is generally non-toxic, it is water soluble, it is likely that it is non-metabolisable at least for humans, and it is easy to manufacture. The present invention therefore also relates to a novel application of AF as a sweetener. Preferably the AF is prepared by the method according to the present invention. Further aspects of the present invention include: a method of preparing the enzyme α-l,4-glucan lyase (GL) comprising isolating the enzyme from algae alone; a nucleotide sequence coding for the enzyme -l,4-glucan lyase, preferably wherein the sequence is not in its natural environment (i.e. it does not form part of the natural genome of a cellular organism capable of expressing the enzyme, preferably wherein the nucleotide sequence is a DNA sequence; the use of β-cyclodextrin to purify an enzyme, preferably GL. Other preferred embodiments of the present invention include any one of the following: A transformed cell, tissue, organ or host organism having the capability of producing AF as a consequence of the introduction of a DNA sequence as herein described; such a transformed host organism which is a microorganism - preferably wherein the host organism is selected from the group consisting of bacteria, moulds, fungi and yeast; preferably the cell, tissue, organ or host organism is obtained from or is any one of the group consisting of Saccharomyccs, Kluyveromyces, Aspergillus, Trichoderma Hansenula, Pichia, Bacillus Streptomyces, Eschericia such as Aspergillus oryzαe, Sαcchαromyces cerevisiαe, bacillus sublilis, Bacillus amyloliquefascien, Eschericia coli.; A method for preparing the sugar 1,5-D-anhydrofructose comprising the use of a transformed host organism expressing a nucleotide sequence encoding the enzyme -l,4-glucan lyase, preferably wherein the nucleotide sequence is a DNA sequence, preferably wherein the DNA sequence is one of the sequences hereinbefore described; A vector incorporating a nucleotide sequence as hereinbefore described, preferably wherein the vector is a replication vector, preferably wherein the vector is an expression vector containing the nucleotide sequence downstream from a promoter sequence, preferably the vector includes a marker (such as a resistance marker); Cellular organisms, or cell line, transformed with such a vector; A method of producing the product α-l,4-glucan lyase or any nucleotide sequence or part thereof coding for same, which comprises culturing such an organism (or cells from a cell line) transfected with such a vector and recovering the product. In particular, in the expression systems, the enzyme should preferably be secreted to ease its purification. To do so the DNA encoding the mature enzyme is fused to a signal sequence, a promoter and a terminator from the chosen host. For expression in Aspergillus niger the gpdA (from the Glyceraldchyde-3-phosphate dehydrogenase gene of Aspergillus nidulans) promoter and signal sequence is fused to the 5' end of the DNA encoding the mature lyase. The terminator sequence from the A. niger trpC gene is placed 3' to the gene (Punt, P.J. et al 1991 - (1991): J. Biotech. 17, 19-34). This construction is inserted into a vector containing a replication origin and selection origin for E. coli and a selection marker for A. niger. Examples of selection markers for A. niger are the amdS gene, the argB gene, the pyrG gene, the hygB gene, the BmlR gene which all have been used for selection of transformants. This plasmid can be transformed into A. niger and the mature lyase can be recovered from the culture medium of the transformants. Eventually the construction could be transformed into a protease deficient strain to reduce the proteolytic degradation of the lyase in the culture medium (Archer D.B. et al 1992 - Biotechnol. Lett. 14, 357-362). Instead of Aspergillus niger as a host, other industrial important microorganisms for which good expression systems are known could be used such as: Aspergillus oryzae, Aspergillus sp., Trichoderma sp., Saccharomyces cerevisiae, Kluyveromyces sp., Hansenula sp., Pichia sp., Bacillus subtilis, B. amyloliquefaciens, Bacillus sp., Streptomyces sp. or E. coli. Also, other forms of algae may be used. The following sample was accepted as a deposit in accordance with the Budapest Treaty at the recognised depositary The Culture Collection of Algae and Protozoa (CCAP) at Dunstaffnage Marine Laboratory PO Box 3, Oban, Argyll, Scotland, United Kingdom, PA34 4AD on 11 October 1994: Gracilariopsis lemaneiformis (CCAP 1373/2) - [ref. GLSC-1 (California)]. Thus a highly preferred embodiment of the present invention includes a GL enzyme or a nucleotide sequence coding for same obtainable from the algae that is the subject of deposit CCAP 1373/2. The present invention will now be described only by way of example, in which reference shall be made to Figures which shows the results of some electrophoretic studies on algal α-l,4-glucan lyases, and Figure 2 which shows the results of some isoelectric focus studies on α-l,4-glucan lyases on a gel with a pH gradient of pH 3 to pH 9. Figures 1 and 2 are are described in more detail later. PREPARATION OF Q.-1.4-GLUCAN LYASE The enzyme α-l,4-glucan lyase according to the present invention (e.g. for use in preparing AF) may be isolated from algae alone, preferably Gracilariopsis lemaneiformis, more preferably Gracilariopsis lemaneiformis from Santa Cruz, (California). The initial enzyme purification can be performed by the method as described by Yu et al (ibid). However, preferably, the initial enzyme purification includes an optimized procedure in which a solid support is used that does not decompose under the purification step. This gel support further has the advantage that it is compatible with standard laboratory protein purification equipment. The details of this optimized purification strategy are given later on. The purification is terminated by known standard techniques for protein purification. The purity of the enzyme can be readily established using complementary electrophoretic techniques. CHARACTERISATION OF THE ENZYME Amino acid sequence analysis The α-l,4-glucan lyase from Gracilariopsis lemaneiformis was digested with either endoproteinase Arg-C from Clostridium histolyticum or endoproteinase Lys-C from Lysobacter enzymogenes, both sequencing grade purchased from Boehringer Mannheim, Germany. For digestion with endoproteinase Arg-C, freeze dried lyase (0.1 mg) was dissolved in 50 μl 10 M urea, 50 mM methylamine, 0.1 M Tris-HCl, pH 7.6. After overlay with N 2 and addition of 10 μl of 50 mM DTT and 5 mM EDTA the protein was denatured and reduced for 10 min at 50°C under N,. Subsequently, 1 μg of endoproteinase Arg-C in 10 μl of 50 mM Tris-HCl, pH 8.0 was added, N 2 was overlayed and the digestion was carried out for 6h at 37°C. For subsequent cysteine derivatization, 12.5 μl 100 mM iodoacetamide was added and the solution was incubated for 15 min at RT in the dark under N 2 . For digestion with endoproteinase Lys-C, freeze dried lyase (0.1 mg) was dissolved in 50 μl of 8 M urea, 0.4 M NH 4 HCO 3 , pH 8.4. After overlay with N 2 and addition of 5 μl of 45 mM DTT, the protein was denatured and reduced for 15 min at 50°C under N 2 . After cooling to RT, 5 μl of 100 mM iodoacetamide was added for the cysteines to be derivatized for 15 min at RT in the dark under N 2 . Subsequently, 90 μl of water and 5 μg of endoproteinase Lys-C in 50 μl of 50 mM tricine and 10 mM EDTA, pH 8.0, was added and the digestion was carried out for 24h at 37°C under N 2 . The resulting peptides were separated by reversed phase HPLC on a VYDAC C18 column (0.46 x 15 cm; 10 μm; The Separations Group; California) using solvent A: 0.1% TFA in water and solvent B: 0.1% TFA in acetonitrile. Selected peptides were rechromatographed on a Develosil C18 column (0.46 x 10 cm; 3 μm; Dr. Ole Schou, Novo Nordisk, Denmark) using the same solvent system prior to sequencing on an Applied Biosystems 476A sequencer using pulsed-liquid fast cycles. The amino acid sequence information from the enzyme derived from Gracilariopsis lemaneiformis is shown below (corresponds to SEQ. ID. No.3) where the sequenced peptides are underlined. MFPTLTFIAP SALAASTFVG ADIRSGIRIQ SALPAVRNAV RRSKHYNVSM TALSDKOTAI SIGPDNPDGI NYQNYDYIPV AGFTPLSNTN WYAAGSSTPG GITDWTATMN VKFDRIDNPS YSNNHPVQIQ VTSYNNNSFR IRFNPDGPIR DVSRGPILKQ QLTWIRNQEL AQGCNPNMSF SPEGFLSFET KDLNVIIYGN CKMRVTKKDG YLVMENDECN SQSDGNKCRG LMYVDRLYGN AIASVQTNFH KDTSRNEKFY GAGEVNCRYE EQGKAPTYVL ERSGLAMTNY NYDNLNYNQP DVVPPGYPDH PNYYIPMYYA APWLVVOGCA GTSKQYSYGW FMDNVSQSYM NTGDTAWNCG QENLAYMGAQ YGPFDQHFVY GDGDGLEDVV KAFSFLQGKE FEDKKLNKRS VMPPKYVFGF FQGVFGALSL LKQNLPAGEN NISVQEIVEG YQDNDYPFEG LAVDVDMQDD LRVFTTKPEY WSANMVGEGG DPNNRSVFEW AHDRGLVCQT NVTCFLRNDN SGKPYEVNQT LREKQLYTKM DSLNNTDFGT TSDGPGDAYI GHLDYGGGVE CDAIFPDWGR PDVAQW GEN YKK ESIGLC FV QDMTVPA MMPHRLGDAV NKNSGSSAPG WPNENDPSNG RYNWKSYHPQ VLVTDMRYGA EYGREPMVSQ RNIHAYTLCE STRREGIVGN ADSLTKFRRS YIISRGGYIG NQHFGGMWVG DNSATESYLQ MMLANIINMN MSCLPLVGSD IGGFTQYNDV GDPTPEDLMV RFVQAGCLLP WFRNHYDRWI ESKKHGKKYQ ELYMYPGQKD TLKKFVEFRY RWQEVLYTAM YQNATTGEPI IKAAPMYNND VNVYKSQNDH FLLGGHDGYR ILCAPVVREN ATSREVYLPV YSKWFKFGPD FDTKPLENEI QGGQTLYNYA APLNDSPIFV REGTILPTRY TLDGVNKSIN TYTDNDPLVF ELFPLENNQA HGLFYHDDGG VTTNAEDFGK YSVISVKAAQ EGSQMSVKFD NEVYEHQWGA SFYVRVRNMG APSNINVSSQ IGQQDMQQSS VSSRAQMFTS ANDGEYWVDQ STNSLWLKLP GAVIQDAAIT VR In addition, for the characterization of α-l,4-glucan lyase from a red seaweed Gracilariopsis lemaneiformis collected in Santa Cruz, California and apparently not infected by fungi, the following amino acid composition of the lyase was found: Amino acid residues mol % of each residue Asx 15.42 Thr 5.24 Ser 6.85 Glx 9.46 Pro 5.46 Gly 9.08 Ala 5.38 l/2Cys 1.57 Val 6.60 Met 2.90 lie 3.66 Leu 6.00 Tyr 6.00 Phe 4.37 His 1.65 Lys 4.44 Arg 4.17 Trp 1.75 Total: 100.00 Comparing the peptide sequences from the Califomian algae with the amino acid sequence from a fungally infected algae from China (described in co-pending PCT patent application No. PCT/EP/0339) showed a high degree of homology (72-79% identity between the amino acid sequence in SEQ. ID. No. 3 and No. 4 generated from the PCR fragments and the corresponding sequences in the GL obtained from the algae from China) between the protein sequences. The alignment of the protein sequences showed that sequence position 1 to 50 of SEQ. ID. No. 3 represents a signal sequence and sequence position 51 to 1092 represents the mature protein. SEQ. I.D. No.3 has the following characteristics: Number of residues: 1092 Molecular weight (MW): 123169 Amino acid composition (including the signal sequence): 64 Ala 14 Cys 18 His 33 Met 56 Thr 48 Arg 55 Gin 45 He 49 Phe 22 Trp 89 Asn 49 Glu 65 Leu 59 Pro 67 Tyr 73 Asp 94 Gly 46 Lys 73 Ser 73 Val SEQ. ID. No. 4 is a partial sequence corresponding to amino acid 287 to 861 in SEQ. ID. No. 3. The identity between the two sequences is 81%. DNA sequence analysis DNA from Gracilariopsis lemaneiformis was isolated as described by Saunders (1993) with the following modification: The polysaccharides were removed from the DNA by ELUTIP-d (Schleicher & Schuell) purification instead of gel purification. (Ref: Saunders, G.W. (1993). Gel purification of red algal genomic DNA: An inexpensive and rapid method for the isolation of PCR-friendly DNA. Journal of phycology 29(2): 251-254 and Schleicher & Schuell: ELUTIP-d. Rapid Method for Purification and Concentration of DNA.) For PCR, the appropriate DNA molecule was prepared by use of the Gene Amp DNA Amplification Kit (Perkin Elmer Cetus, USA) and in accordance with the manufactures instructions except that the Taq polymerase was added later (see PCR cycles) and the temperature cycling was changed to the following: PCR cycles : no of cycles C time (min. ) 1 98 5 60 5 addition of Taq polymerase and oil 35 94 1 47 2 72 3 1 72 20 PCR fragments were cloned into pT7Blue (from Novagen) or Script™SK(+) following the instructions of the supplier. The double stranded DNA was sequenced essentially according to the dideoxy method of Sanger et al. (1979) using the Auto Read Sequencing Kit (Pharmacia) and the Pharmacia LKB A.L.F.DNA sequencer. (Ref: Sanger, F., Nicklen, S. and Coulson, A.R.(1979). DNA sequencing with chain-determinating inhibitors. Proc. Natl. Acad. Sci. USA 74: 5463-5467.). The sequences are shown as SEQ. ID. No.s 1-2. For the initial PCR, the following three oligonucleotide sequences were generated from two peptide sequences from the Califomian algae to generate a PCR fragment of app. 970 bp. Primer 1: ATGA GATC)AA(CT)TA(CT)AA(CπTA(CT)GA(CT)AA Primer 2: (AG)TG(GATC)GGCATCAT(GATC)GC(GATC)GG(GATC)AC Primer 3: GTCAT(GA)TC(CT)TGCCA(GATC)AC(GA)AA(GA)TC Primer 1 corresponds to the codons for amino acids 287-293 in SEQ. I.D. No. 3. Primer 2 and primer 3 correspond to codons (of the complementary strands) for amino acids 608-614 and 599-607 of SEQ. ID. No. 3, respectively. Primer 1 was used as the upstream primer and primer 2 was used as the downstream primer in the first PCR amplification. In the second PCR amplification primer 1 was used as the upstream primer and primer 3 was used as the downstream primer. A PCR fragment of the expected size was generated and cloned into the pT7blue vector from Novagen. Two independent plasmids containing a PCR fragment were sequenced and it was seen that those two cloned PCR fragments contained the codons for peptide sequences originating from two different proteins. This indicates that there are at least two different genes coding for -l,4-glucan lyase in the Califomian algae containing sequences shown as SEQ. ID. No.s 1-2 - their putative amino acid sequences are shown as SEQ. ID. No.s 3-4. Further PCR using the Pfu polymerase from Stratagene were made according to the manufactures instruction using the same temperature cycling as for the Taq polymerase. The PCR fragments were cloned into either the pT7Blue plasmid from Novagen or the pCR-Script™ SK(+) plasmid from Stratagene. Four additional PCR amplifications were performed using the following primers. For the first PCR the primer GA(CT) AA(CT) CC(GATC) GA(CT) GG(GATC) AT(ATC) (GA)A(CT) TA corresponding to codons for amino acids 65-72 of SEQ. ID. No.3 was used as the upstream primer and the primer (GA)GA (TG)AC ATT (GA)TC CA(AT) AAA CCA generated from the initial PCR corresponding to codons (of the complementary strand) for amino acids 340-346 of SEQ. ID. No.3 was used as the downstream primer. In the second PCR the primer GT(GA) GAT GT(GT) GAT ATG CAA (GC)A(AT) GA generated from the initial PCR corresponding to codons for amino acids 463-470 of SEQ. ID. No.3 was used as the upstream primer and the primer CCA CAT (GATC)CC (GATQCC (GA)AA (GA)TG (CT)TG (GA)TT corresponding to codons ( of the complementary strand) for amino acids 711-718 of SEQ. ID. No.3 was used as the downstream primer. In the third PCR the primer GTG AGT CTA CTA GGA GGG AA generated from the initial PCR corresponding to codons for amino acids 389-395 of SEQ. I.D.No.4 was used as the upstream primer and the primer A(GA) (GA)AA (GA)TG (GA)TC (GA)TT (CT)TG corresponding to codons (of the complementary strand) for amino acids 566-571 of SEQ. ID. No. 4 was used as the downstream primer. In the fourth PCR the primer TTC CCA GA(CT) TGG GGT CGA CC generated from the initial PCR corresponding to codons for amino acids 575-581 of SEQ. ID. No. 3 was used as the upstream primer and the primer GT(GA) AA(GA) TC(GATC) GG(GATC) CC(GA) AA corresponding to codons (of the complementary strand) for amino acids 897-902 of SEQ. ID. No. 3 was used as the downstream primer. The first PCR amplification generated a DNA sequence corresponding to nucleotides 193-1038 in SEQ. ID. No. 1. The second PCR amplification generated DNA sequences corresponding to nucleotides 1387-2154 in SEQ. ID. No. 1 and nucleotides 526-1284 in SEQ. ID. No. 2. The third PCR amplification generated a DNA sequence corresponding to nucleotides 1165-1712 in SEQ. ID. No. 2. The fourth PCR amplification generated a DNA sequence corresponding to nucleotides 1723-2706 in SEQ. ID. No. 1. To obtain the 5' and 3' end of SEQ. ID. No.3 the RACE (rapid amplification of cDNA ends) procedure was performed (Michael, A.F., Michael, K.D. & Martin, G.R.(1988). Proc.Natl.Acad.Sci.USA 85:8998-9002) using the 5'Race system from Gibco BRL for the 5'Race. Total RNA was isloatcd according to Collinge et /.(Collinge, D.B., Milligan, D.E., Dow, J.M., Scofield, G. & Daniels, M.J.(1987). Plant Mol Biol 8:405- 414). The 5'Race was done according to the protocol of the manufacturer, using lμg of total RNA and the sequence GGTAGC GGTCCA GTC GGT GAT GCC (identical to the complementary strand of nucleotides 301-324 in SEQ. ID. No. 1) as a primer in the first strand synthesis. The sequence AGA GCC GGC AGC ATA CCA GTT GGT GTT GG T) identical to the complementary strand of nucleotides 260-288 in SEQ. ID. No. 1 was used for the PCR amplification. In the 3'Race the following primer GAA GGA TCC GTC GAC ATC GAT AAT ACG ACT GAA TTC GGG ATT TTT TTT TTT TTT TTT was used for the first strand synthesis. The gene specific primer GACGGCTATCGTATTCTCTGC identical to nucleotides 2599-2619 in SEQ. ID. No. 1 was used in the first PCR amplification, while primer TAC CTG CCTGTG TATAGCAAG corresponding to nucleotides 2659-2679 was used as the gene specific primer in the second PCR amplification. The sequence AAG GAT CCG TCG ACA TCG ATA AT was used as the downstream primer in both PCR amplifications. The GeneAmp RNA PCR kit from Perkin Elmer was used for the 3'Race. After the 5' and 3' Race the PCR fragments were blunt ended with the Pfu polishing kit from Stratagene before cloning into the pCR Script™ SK(+) plasmid. BIOCHEMICAL CHARACTERIZATION Electrophoretic properties of the α-l,4-glucan lyase purified from the red alga Graci¬ lariopsis lemaneiformis collected in Santa Cruz, Califomian (USA), as compared with lyases collected in Qingdao (China) and Sucre Pennisula (Nenezuella), and with lyases isolated from the fungi Morchella costata, M. vulgaris. Two lyases (GLscl-lyase and GLsc2-lyasc) were purified from the red alga Gracilariopsis lemaneiformis collected in Santa Cruz, California (USA), using the procedure developed for the purification of the lyase from the red alga collected from Qingdao China. The two forms were purified to electrophoretic homogeneity (Figure 1A and IB). Partial amino acid sequences were obtained from the purified GLscl- lyase and were used to generate PCR primers. The molecular mass was estimated to 116 kDa for both GLscl-lyase and GLsc2-lyase, by the SDS-PAGE method (Figure 1A). On the native PAGE (Figure IB), GLscl-lyase and GLsc2-lyase migrated slower than GLl-lyase. On the isoelectrofucsiπg gel, GLscl-lyase showed a p/ of 4.1 (Fig. 2). A comparison of the relative migration rates and the pi values of the different lyases studied are listed in the following table. Enzyme name Origin Migration p/ GLl-lyase QC ++++ 3.8 GLscl-lyase SCC +++ 4.1 GLsc2-lyase SCC +++ 4.1 GLv-lyase SpV +++ 4.1 MV-lyase MvA ++ 4.4 C-lyase McA + 4.5 CODES: QC = Qingdao, China SCC = Santa Cruz, California SpV = Sucre pennisula, Venezuela MvA = Morchella vulgaris, ATCC McA = Morchella costata, ATCC The relative migration rates were estimated from native PAGE on gels with 8-25% gradient; the p/ values were estimated by isoelectrofocusing on gels with a pH gradient of 3-9. From the table it is seen that the GLql-lyase exhibited the fastest migration rate on native-PAGE and exhibited the lowest p/ values of 3.8 while the MC-lyase showed the slowest migration rate and the highest p/ value of 4.5. The Figures are now discussed in more detail. Figure 1. Electrophoresis of algal -1.4-glucan lyases. A. SDS-PAGE on 8-25% gradient gels. The gel was stained with PhastGel Blue R. Lane 1: the molecular markers of phosphorylase b (97.4kDa); bovine serum albumin (67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa), soybean trypsin inhibitor (20.1 kDa), and β-lactalbumin (14.4 kDa). Lane 2: the purified GLql-lyase from the red alga Gracilariopsis lemaneiformis collected in Qingdao (China). Lanes 3 and 5: the purified GLscl-lyase from the red alga Gracilariopsis lemaneiformis collected in Santa Cruz, California (USA). Lane 4: the purified GLsc2-lyase from the red alga Gracilariopsis lemaneiformis collected in Santa Cruz, California (USA). B. Native-PAGE on 8-25% gradient gel. The gel was stained with PhastGel Blue R. Lane 1 and 4: the purified GLql-lyase from the red alga Gracilariopsis lemaneiformis collected in Qingdao (China). Lane 2: the purified GLsc2-lyase from the red alga Gracilariopsis lemaneiformis collected in Santa Cruz, California (USA). Lane 3: the purified GLscl-lyase from the red alga Gracilariopsis lemaneiformis collected in Santa Cruz, California (USA). Lane 5: the protein markers: thyroglobulin (669 kDa), ferritin (440 kDa), catalase (232 kDa), lactate dehydrogenase (140 kDa) and albumin (67 kDa). Figure 2. Isoelectric focusing of the α-1.4-glucan Ivases on a gel with a pH gradient of pH 3 to pH 9. The gel was stained with PhastGel Blue R. Lane 1: GLscl-lyase purified from Gracilariopsis lemaneiformis collected in Santa Cruz California showing a p/ of 4.1. Lane 2: GLql-lyase purified from G. lemaneifromis collected in Qingdao (China) showing a pi of 3.8. Lane 3: the p/ markers: 1 amyloglucosidase (3.50), 2 soybean trypsin inhibitor (4.55), 3 β-lactoglobumin A (5.20), 4 bovine carbonic anhydrase B (5.85), 5 human carbonic anhydrase B (6.55), 6 horse myoglobin (acidic, 6.85), 7 horse myoglobin (basic 7.35), 8 lentil lectin (acidic 8.15), 9 lentil lectin (middle, 8.45), 10 lentil lectin (baic, 8.65). Further studies showed that K„, was 3.76 mg/ml for amylopectin and 3.37 mg/ml for glycogen. DEGRADATION STUDIES The degradation rates of the lyase on various substrates are given below. Substrate AF released (nmol) Maltose 657 Maltotriose 654 Maltotetraose 670 Maltopentaose 674 Maltohexaose 826 Maltoheptaose 865 Dextrin 20 775 Dextrin 15 775 Dextrin 10 844 Amylopectin 732 Glycogen 592 Reaction conditions: The reaction mixture contained 10 mM of HOAc-NaOAc (pH 3.8). The substrate concentration was 10 mg/ml. The final volume was 100 ul after the addition of lyase and water. The reaction time was 40 min at 45°C. The lyase was not able to degrade pullulan, nigeran tetrasaccharide, trehalose, isomaltose, glucose, a-, β- and r-cyclodextrins. The lyase degraded panose and nigcrose though at a slow rate. The temperature optimum for the lyase was 48°C when amylopectin was used as substrate and 50°C when glycogen was used as substrate. At 50°C, the reactivity of glycogen was similar to that of amylopectin; below 50°C, amylopectin was a better substrate than glycogen. The pH optimum range for the lyase was between pH 3.5 and pH 7.0; the optimal pH was 3.8. The buffers used in the pH tests were glycine-HCl (pH 2.2-3.6); NaOAc- HOAc (pH 3.5-5.5); Mes-NaOH (pH 5.5-6.7); Mops-NaOH (pH 6.0-8.0) and bicine-NaOH (pH 7.6-9.0). All buffers used were 40 mM. At a final concentration of 2 mM, p-chloromercuribenzoic acid (PCMB) inhibited the lyase activity by 96%, indicating the -SH group(s) is essential for the enzymatic activity. In immunological tests of the lyase by Western blotting, the results showed that the antibodies to the algal lyase could recognize the fungal lyase (of our earlier PCT patent application PCT/EP94/03397) both in cell-free extracts and in purified form, as revealed by Western blottings. The antibodies to the algal lyase purified form the algae collected in China (of our earlier PCT patent application PCT/EP94/03397) also recognized the lyase from the algae collected in Santa Cruz, California. Further aspects and experiments relating to the enzyme according to the present invention will now be described. THE SOLUBLE ENZYME SYSTEM 1. Effect of pH on the stability and activity of the lyase isolated from Gracilariopsis lemaneiformis. Two buffer systems, namely HOAc and NaOAc and sodium citrate - citric acid in a concentration of 5 mM - were tested at 37°C. The pH range tested was from pH 3 to pH 5.2. The lyase showed maximum activity in a pH range between 3.6 to 4.2. At pH 3, the stability and activity of the enzyme decreased by about 90%. At pH 5.2, the activity decreased by about 64%. However, the enzyme was considerably more stable at this pH than at pH 3, as the AF yield obtained at pH 5.2 was 75% of the AF yield obtained at pH 3.8. Slightly higher AF yield was obtained in the HOAc and NaOAc buffer than in citrate buffer. This is not due to any differential effect of the two buffers (final cone, is 125 μM in the AF assay mixture) in the AF assay method. 2. Effect of temperature on the activity and stability of the lyase. This experiment was conducted at optimal pH range. At 25°C the production of AF was linear up to at least 9 days. This indicates that no loss of activity and stability of the lyase occurred within 9 days. With increasing temperature, the stability of the enzyme decreased. The half life of the enzyme activity at the following temperature was: 30°C 5 days 37°C 2.5 days 40°C less than 1 day 50°C less than 1 day 3. Effect of substrate concentration on the stability of the lyase and AF yield. It was observed that amylopectin and dextrins have a stabilizing effect on the lyase while the smallest substrate maltose does not. This was verified for both the soluble enzyme system and the immobilized enzyme system. AF yield increases with the increase in amylopectin concentration up to 25%. In the case of dextrin, the AF yield decreases when the concentration exceeds 30% (30%, 40% and 50% were tested). 4. Activation and inactivation of lyase No metal ions were found to be necessary for the activity and the enzyme catalysed reaction can surprisingly proceed in pure water. The fact that the addition of EDTA in the reaction mixture up to 20 mM had little effect on the activity clearly demonstrates that metal ions are not essential for the activity of the lyase enzyme according to the present invention. This means that in the AF purification step, the ion exchange chromatography step that takes away salts from the reaction system can be omitted, if water is used as reaction medium. However, inclusion of NaCI in the reaction mixture in a concentration of 0.85% (0.145 M) can increase the AF yield up to 1-fold. 5. Substrate Specificity Upon cooling solubiiized starch will tend to form rigid gels when the starch concentration becomes to high. Therefore it is an advantage to utilize partly degraded starch as substrate for the 1,4-glucan lyase. The specificity of α-l,4-glucan lyase for different oligosaccharides was tested. The oligosaccharides were maltose (G2), maltotriose (G3), maltotetraose (G4), malto- pentaose (G5), maltohexaose (G6) and maltoheptaose (G7). The oligosaccharides were dissolved in H 2 O at a concentration of 8 mg/ml. The enzyme assay contained 150 μl substrate G2/G3/G4/G5/G6/G7, 120 μl 0.1M MES pH 6.3 and 30 μl purified enzyme. The reaction mixture was incubated for 60 min at 30°C. Afterwards the reaction was stopped by boiling for 3 min and 900 μl absolute ethanol was added for precipitation. After centrifugation at 20.000 x g for 5 min at 4°C the supernatant was transferred to a new eppendorf tube and lyophilized. The freeze-dried samples were dissolved in 1000 μl H 2 O and were filtrated through a 0.22 μm Millipore filter before 25 μl of the sample was loaded on the Dionex HPLC. 6. HPLC Analyses were performed on a Dionex 4500i chromatography system consisting of a GPM-2 pump and a PED detector which was used in pulse-amperometric detection mode. The anion exchange columns were a CarboPac PA- 100 (4 x 250 mm) and a CarboPac PA- 100 guard column (3 x 25 mm) from Dionex. The eluent were 200 mM sodium hydroxide (A), 500 M sodium acetate (B) and 18 M ohm de-ionized water (C). The pump was programmed in 2 different ways, method no. 1 and method no. 2: Method no. 1: Method no. 2: Standards: Glucose, maltose, maltotriose, maltotctraose, maltopentaose, maltohexaose and maltoheptaose (all from Sigma) and 1,5-anhydrofructose were used as standards. All compounds were dissolved in 18 M ohm de-ionized water which was filtered through a 0.22 μm Millipore filter before use. 7. Results The analyses show that the purified enzyme was able to use maltooligosaccharides as substrate 1 for 1,5-anhydrofructose formation. When maltose was used as substrate, almost no 1,5-anhydrofructose was formed but when the other maltooligosaccharides (G3-G7) were used, high amounts of this compound were produced. It is clear that higher amounts of 1,5-anhydrofructose were obtained when a longer maltoo- ligosaccharide was used. This observation corresponds perfectly well with the theory of the lyase forming 1,5-anhydrofructose from the non-reducing end of the substrate, leaving only the terminal glucose molecule unchanged. 8. Formation of AF α-l,4-glucan lyase according to the present invention hydrolyses starch to the end- product 1,5-anhydrofructose. The end-product was shown by HPLC, method 2. The enzyme assay contained 500 μl amylopectin (20 mg/ml, dissolved in H 2 O), 400 μl 0.1 M MES pH 6.3 and 100 μl purified enzyme. The reaction mixture was incubated at 30°C and the reaction was stopped by boiling after 30 or 120 min incubation. High- molecular oligosaccharides were precipitated by addition of 3 vol abs. ethanol and the sample was centrifuged and frecze-dried as described above. The samples were dissolved in 125 μl H 2 O and 25 μl were applied on the HPLC column. The HPLC elution profile clearly shows that -l,4-glucan lyase produces 1,5- anhydrofructose by hydrolysis of starch. Equal amounts of 1,5-anhydrofructose were found after 30 and 120 min. incubation which indicate that the enzyme activity is not inhibited by the end-product 1,5-anhydrofructose. 13 C NMR spectra (water) of AF prepared in this way shows that it adopts one major form giving rise to the following signals: ό 93.5 (quart, C-2), 81.5 (CH, C-5), 77.7 (CH, C-3), 72.6 (CH 2 , C-1), 69,8 (CH, C-4), 62.0 (CH,, C-6). Assignments are based on H-H C-H and C-H 2D correlation spectra. 9. The cooperative effect of lyase with pullulanase and isoamylase. As it can be seen from the Table below, the inclusion of pullulanase in the reaction mixture will obviously increase the AF yield by about 15-23%, depending on whether soluble starch or amylopectin is used as substrate. The cooperation of pullulanase and lyase in the production of AF. Substrate Lyase Pullulanase AF Yield (%) Glc Yield (%) Solubl. Starch 51 0 0 0.37 66.0 3.9 Amylo 48.0 0 -pectin 0.33 71.3 3.7 +, enzyme added, - enzyme omitted. The reaction mixture contained 0.3 ml 2% potato amylopectin (Sigma) in water or 0.3 ml 2% soluble starch (Merck), 2 μl lyase and 0.36 units pullulanase (BM) as indicated. The reaction was carried out at 30°C for 1 day. At the end of the reaction, samples were taken for AF and Glc analysis. In the case of isoamylase, the advantage is that the optimal pH of the lyase overlaps with that of Pseudomonas isoamylase (pH 3.0-4.5). The problem, however, is that isoamylase will produce an excess amount of long chain amylose that precipitates from the solution, and therefore is no longer suitable as a substrate for the lyase. It can be expected that the cooperation of the lyase with isoamylase will be efficient, if the chain of amylose is not too long. THE IMMOBILIZED ENZYME SYSTEM Immobilization of the lyase was achieved by using succinimide-activated Sepharose (Affigel 15 gel, Bio-Rad) and glutaradchye-activated Silica gel (BM). The recovery of lyase activity after immobilization on Affigel 15 gel was between 40% to 50%. There may be some lyase that is still active after immobilization, but is inaccessible to the substrate because of the steric hindrance, especially in the case of macromolecules like starches. Immobilized enzymes used in the industry usually have an activity recovery of around 50%. The most interesting thing of the Affigel 15 gel immobilized lyase is that its stability has been greatly improved at pH 5.5. When the column was operated at this pH, the stability was at least 16 days long. The Ph shift in the stability is very important considering the optimal pH of pullulanase which is around pH 5.5. This is the prerequisite for the lyase and pullulanase to cooperate efficiently in the same reactor with the same physico-chemical environment. The soluble lyase has an optimal pH between 3.6 and 4.2, and at this pH range pullulanase shows little or no activity. With the silica gel immobilized lyase, the activity recovery is very high, around 80- 100%. However, the silica gel immobilized enzyme was not stable when the column was operated neither at pH 3.8 nor pH 5.5. It is possible that some lyase was adsorbed on the surface of the silica gel beads and was slowly released from the silica gel after each washing of the column. It may therefore be the adsorbed lyase that contributes to the high recovery rate and the decrease in column activity. PURIFICATION OF AF 1. The lyase-Amylopectin/Soluble Starch System In this system, the reaction system contained AF, limit dextrin, the lyase, and buffer salts at the end of the reaction. AF was separated from the macromolecules (limit dextrin and the lyase) by ethanol (final cone. 50%) precipitation. Unprecipitated low- molecular-weight amylopectin was separated by ultrafiltration using Amicon YM3 membranes (cut-off 3,000). Ethanol was removed by evaporation at 40°C in a rotary evaporator. Buffer salts were removed from AF by mixed ion exchangers. Purified solid AF was obtained by freeze-drying. 2. The Lyase-Pullulanase/Amylopectin Soluble Starch System. In this system the final products are AF and glucose. If at least a substantially pure sample of AF is to be prepared, the by-product glucose must be removed. This can be achieved by enzymatic methods. First the glucose is converted into gluconic acid and hydrogen peroxide by glucose oxidase. Catalase is needed to dispel H 2 O 2 formed. H 2 O 2 will oxidize AF into two new compounds which are at present of unknown structure. The other impurities in the AF preparation are the oxidation products of AF. It was observed that AF can slowly be oxidized by air-level of oxygen, especially at high temperature, high AF concentration and long time of exposure. Gluconic acid was removed together with the buffer salts by ion exchange chromatography. In this system, the low-molecular-weight amylopectin molecules may alternatively be hydrolysed by amyloglucosidase instead of using ultrafiltration. 3. The purity checking of AF. The purity of the AF preparations were confirmed by TLC, Dionex and NMR. 4. Analysis of the antioxidative activity of anhydro fructose. Electrochemical oxygen consumption: The activity of AF was investigated in a methyl linoleate emulsion as described by Jorgenscn and Skibsted (Z. Lebensm. Unters. Forsch. (1993) 196: 423-429) with minor modifications: To 5.00 ml of a 1.33 mM methyl linoleate emulsion in 5.0 M aqueous phosphate buffer with pH = 5.8 and 0.2 w/w % Tween 20 as emulsifier was added AF in the following concentrations: 0, 15, 146 and 680 μM. The oxidation in the system was initiated by addition of 50 μl 0.26 M metmyoglobin (MMb) final concentration 0.26 mM. Immediately after initiating the reaction the sample was injected to a thermostated (25.0 ± 0.1°C) 70 μl closed cell, effectively excluding diffusion of oxygen into the system. The oxygen consumption was measured by a Clark electrode, which was connected to a PC data collection program. The relative oxygen concentration (%) was registered every 30s. The results of the experiments produced curves corresponding to oxygen consumption. For samples without addition of AF a relative decrease in oxygen concentration is seen immediately after injection of the sample. For samples containing AF a lag-phase is observed before the curve breaks off and the oxygen concentration is reduced. After the lag-phase only a minor reduction in the oxygen consumption rate is observed compared to samples without AF added. A tendency for samples having the highest amount of AF to have the longest lag-phase is observed. Also, the rate for oxygen consumption is lower for these samples, which was seen by the smaller slope of the curves compared to the slope for the references (0 μM). ESR analysis: Hydroxyl radicals were generated by a Fenton reaction with H 2 O 2 (0.17 mM) and FeSO 4 (4.8μM). The generated radicals were trapped by 5,5-dimethyl-l-pyrroline N- oxide (DMPO, 9.7 mM). AF was added in concentrations of 1.3 mM and 6.3 mM. A water soluble extract of rosemary (Rosmarinus officinalis L.) was analyzed in a concentration of 0.25 mg/ml (in grams equivalent to 1.26 mM AF). Measurements were carried out at room temperature (20 ± 1°C) after 120 s and repeated for the same reaction mixture after 300 s with the following spectrometer settings: Center field 3475.60 G; sweep width 55 G; microwave power 20 tnW; modulation frequency 100 kHz; modulation amplitude 1.01 G; receiver gain 1.00 • 10 5 ; conversion time 81.92 ms time constant 163.84 ms and sweep time 83.89 s. The results showed that the generated hydroxyl radicals were trapped by DMPO. The spin adduct gives rise to a characteristic 1:2:2:1 ESR spectrum. The peak height of the spectrum is proportional to the quantitative amount of generated spin adduct. Addition of both DMPO and AF will set up a competition between the spin trap and AF. A reduction of peak height will indicate a good scavenging activity of AF. Table: Peak height of ESR-spectra. H 2 O 2 = 0.17mM and Fe 2+ = 4.8 μM. At a concentration of 1.3 mM AF no scavenging activity of hydroxyl radicals is seen, at 6.3 mM Af the peak height is reduced, indicating that a part of the generated hydroxyl radicals is scavenged by AF. USE OF AF AS AN ANTI-OXIDANT 1. Use of AF as an anti-oxidant in a 50% mayonnaise. 50% mayonnaise is used for salads, open sandwiches, etc. in both the catering and the retail trades. The low oil content of 50% mayonnaise makes it suitable for low- calorie applications. A typical mayonnaise composition is as follows: MAYODAN 602 ensures a fine, stable oil dispersion and the required viscosity, thereby providing 50% mayonnaise with a long shelf life. Flavouring 10251 is a natural lemon flavouring which provides mayonnaise with the fresh taste of lemon. Typically the mayonnaise is prepared by the following method: 1) Dry mix the MAYODAN 602, sugar and salt. Disperse in oil in a ratio of 1 part powder to 2 parts oil. 2) Add flavouring and potassium sorbate to the water and pour into the Koruma mixer. Add 1). 3) Add the egg yolk. 4) Add the oil continuously in a vacuum. 5) After 2/3 of the oil has been added (slowly), blend the tarragon vinegar with the remaining 1/3 of the oil, and add. The following data show that when AF is added to the mayonnaise as an anti-oxidant the results are comparable to the known food anti-oxididants GRINDOX 142 and GRINDOX 1029. (All percentages are by weight) In the test procedure the anti-oxidants were added to the mayonnaise to provide an anti-oxidant concentration in the order of about 500 ppm. The mayonnaise was then placed in a bomb calorimeter at temperature 80°C containing pure O 2 . An induction period to the onset of substantial oxidation of the product is then measured. The results were as follows. _ 39 (IP hours = Induction Period) These results show that AF is an excellent food anti-oxidant and is comparable with the known foodstuffs anti-oxidants GRINDOX 142 or GRINDOX 1029. 2. Use of AF as an anti-oxidant in a salad dressing YOGURT SALAD DRESSING WITH 50% OIL Yogurt salad dressing with 50% oil is used for salads, potatoes, raw vegetable salad, meat, fish and boiled vegetables. MAYODAN 525 provides unique emulsion stability, prevents syneresis, ensures uniform oil dispersion and viscosity, improves tolerance to production processes and ensures a long shelf life. Flavouring 2072 is a nature-identical, acid masking flavouring reducing the acidulated taste of dressing without affecting its pH value. Method 1. Dry mix MAYODAN 525, sugar and salt. Disperse in oil in a ratio of 1 part powder to 2 parts oil. 2. Fill flavouring, potassium sorbate and yogurt into the Koruma mixer. Add 1). 3. Add the egg yolk. 4. Add the oil continuously in a vacuum. 5. After 2/3 of the oil has been added (slowly), blend the vinegar with the remaining 1/3 of the oil, and add. 6. Add spices if required. Test results (IP - Induction Period); (PF - Protection Period) Protection Factor (PF): For each temperature defined as PF = IP of the oil with added antioxidant/IP of the same oil without added antioxidant Life extension (LE) %: LE = (PF - 1.0) x 100 FURTHER STUDIES 1. Effect of alcohols in increasing the activity and stability of the lyase purified from the algae. 1-propanol, 2-propanol and 1-butanol were tested at the following concentrations (0%, 1%, 5% and 10%). The optimal concentration of 1-propanol was 5% which increased the AF yield by 34% after 6 days of incubation; the optimal concentration for 2-propanol was 1% which increased the AF yield by 20% after 10 days incubation; the optimal concentration for 1-butanol was 5% which increased the AF yield by 52% after 3-day incubation. Ethanol was tested at the following concentrations (0, 1, 3, 5, 7, 9, 11, 13, 15%). The optimal concentration for 7 days incubation was 5% which increased the AF yield by 12%. For 10 days incubation the optimal concentration was 3% which increased AF yield by 16%. The effect of 1-propanol: 2. Effect of different reaction media upon the production of AF by the lyase purified from the algae The results (see table below) indicate that the best reaction medium is 5 mM of HOAc-NaOAc (pH 3.9) (BACE for short) and containing mM concentrations of Na-,- EDTA. The production of AF using either pure water or 0.85% NaCI as reaction medium decreased the yield. Inclusion of 0.85% of NaCI in BACE also decreased the AF yield. Reaction Reaction Time (days) Media The following buffers: Mes-NaOH, Mops-NaOH, Hepes-NaOH, and Bicine-NaOH were the optimal reaction media for the lyase. 3. The effect of endoamylases and debranching enzymes upon the AF production. Endoamylase The starch used for AF production may first be liquified either by endoamylases, or by acid hydrolysis. Endoamylase degraded starch is more suitable as substrate for the lyase as compared to native starch. Starch has a limited solubility at the temperature used for the lyase- catalyzed reaction. Treatment of starch with endoamylases led to increased glucose yied. It was found that a reducing matter of around 10-15% (on a dry mater basis) was most suitable as substrate for the lyase with respect to AF yield and further treatment with the endoamylase to a reducing matter of 19% was no longer suitable for the lyase. Pullulanase and isoamylase As seen from the results below, both the isoamylase and the pullulanase increased AF yield by up to 50% at pH 4.5 and 5.0. The reaction system consisted of the lyase from the algae with or without the addition of isoamylase or pullulanase (MegaZyme Ltd.). Amylopectin was used as substrate. The AF produced in the presence of only the lyase was expressed as 100%. The pH of the reaction medium Enzymes added 3.5 4.5 5.0 Lyase only 100 100 100 Lyase + isoamylase 136 152 150 Lyase + pullulanase 132 158 155 4. Reversible and Irreversible Inhibitors of the lyase The reversible inhibitors, Glucose and Maltose. At a substrate concentration of lOmg/ml, the activity for the lyase decreased by 19.3 % in the presence of 0.1 M glucose when amylopectin was used as substrate; the activity was not affected when glycogen was used as substrate. In the presence of 0.1 M of maltose the activity decreased by 48.8 % and 73.4%, respectively for glycogen and amylopectin. It seems that the inhibition by 0.1 M glucose is competitive as increasing the substrate from 1% to 2% decreased the inhibition from 19.3 to 7%, whereas the inhibition by 0.1 M maltose is non-competitive as the increase of substrate did not significantly affect the inhibition degree. The reversible inhibitor deoxyjirimycin At a final substrate concentration of 2%, the activity was decreased to 10.4% for the algal lyase in the presence of 25 μM of deoxyjirimycin, using amylopectin as substrate. At 100 μM, the activity of the lyase was completely lost. Irreversible Inhibitor: PCMB Under the same assay conditions and in the presence of 2 mM PCMB, the activity decreased by 60% for the lyase. SCALE PRODUCTION OF AF 1. Production of AF using dextrin as substrate The reactor contained 1000 g dextrins (obtained by treatment of starch with Termamyl to a final reducing matter of 10 %) in a final volume of 4.6 liter (HOAC-NaOAC, pH 3.9, containing 5 mM Na 2 -EDTA). The reaction was initiated by adding 3 mg purified lyase. The reaction was performed at room temperature. At day 19, another batch of lyase (4 mg) was added. Reaction time (days) 0 1 7 13 19 24 31 AF produced (grams) 0 18 116 195 264 500 668 2. Using 14 C-Starch for the production of 1 C-AF The uniformly labelled 14 C-starch (340 μCi obtained from Sigma) was vacuum-dried to remove the ethanol it contained and then dissolved in 2 ml water. The reaction was initiated by adding 20 μl purified lyase and 20 μl pullulanase (MegaZyme Ltd.) The reaction was performed overnight at 30 °C. At the end of the reaction, the reaction mixture was filtered using a filter with a molecular mass cut off of 10,000 to remove the enzymes and unreacted starch molecules. The filtrate was applied on a Ca 2 carbohydrate column (Chrompack) using a Waters HPLC. Water was used as eluent. The flow rate was 0.5 ml/min. AF was efficiently separated from glucose and maltosaccharides. The pooled AF fractions were freeze- dried and totally 140 μCi , C-AF was obtained. These findings relate to an even further aspect of the present invention, namely the use of a reagent that can increase the hydrophobicity of the reaction medium (preferably an alcohol) to increase the stability and activity of the lyase according to the present invention. This increased stability leads to a increased AF yield. Other modifications of the present invention will be apparent to those skilled in the art without departing from the scope of the invention. [GRINDOX as used herein is a trade mark. MAYODAN as used herein is a trade mark.] SEQUENCE LISTING (1) GENERAL INFORMATION NAME OF APPLICANTS: DANISCO A/S BUSINESS ADDRESS: Langebrogade 1 DK-1001 Copenhagen K Denmark TITLE OF INVENTION: ENZYME SEQ. ID. NO. 1 SEQUENCE TYPE: NUCLEIC ACID MOLECULE TYPE: DNA (GENOMIC) ORIGINAL SOURCE: ALGAL SEQUENCE LENGTH: 3279 BP STRANDEDNESS: DOUBLE SEQUENCE: 10 20 30 -40 50 60 I I I I I I I I I I I I 1 ATGTTTCCTA CCCTGACCTT CATAGCGCCC AGCGCGCTGG CCGCCAGCAC CTTTGTGGGC 61 GCGGATATCC GATCGGGCAT TCGCATTCAA TCCGCTCTTC CGGCCGTGCG CAACGCTGTG 121 CGCAGGAGCA AACATTACAA TGTATCCATG ACCGCATTGT CTGACAAGCA AACCGCTATC 181 AGTATTGGCC CTGACAATCC GGACGGTATC AACTACCAAA ACTACGATTA CATCCCTGTA 2-41 GCGGGCTTTA CGCCCCTCTC CAACACCAAC TGGTATGCTG CCGGCTCTTC CACTCCGGGC 301 GGCATCACCG ACTGGACCGC TACCATGAAT GTCAAATTCG ACCGCATTGA CAATCCGTCG 361 TACTCCAATA ACCATCCTGT TCAGATTCAG GTCACGTCGT ACAACAACAA CAGCTTCAGG 421 ATTCGCTTCA ACCCTGATGG CCCCATTCGT GACGTCTCTC GAGGACCTAT CCTGAAACAG 481 CAACTCACTT GGATTCGAAA CCAGGAGCTG GCGCAGGGAT GTAATCCGAA CATGAGCTTC 541 TCTCCTGAAG CrrTTTTTGTC TTTTGAAACC AAAGACCTAA ACGTTATAAT CTACGGCAAC 601 TGCAAGATGA GAGTCACGAA GAAGGATGGC TACCTCGTCA TGGAGAATGA CGAGTGCAAC 661 TCGCAATCAG ATGGCAATAA GTGTAGAGGA TTGATGTACG TTGACCGGCT ATACGGTAAT 721 GCTATTGCTT CCGTACAAAC GAATTTTCAC AAAGACACTT CTCGGAACGA GAAATTCTAT 781 GGTGCAGGTG AAGTCAACTG TCGCTATGAG GAGCAGGGTA AGGCGCCGAC TTATGTTCTA 841 GAACGCTCTG GACTCGCCAT GACCAATTAC AATTACGACA ACTTGAACTA CAACCAACCA 901 GACGTCGTTC CTCCAGGTTA TCCCGACCAT CCCAACTACT ACATTCCAAT GTACTACGCA 961 GCACCGTGGT TGGTCGTTCA GGGATGCGCG GGGACATCGA AGCAATACTC GTACGGTTGG 1021 TTTATGGACA ATGTCTCTCA GTCGTACATG AACACTGGAG ATACGGCGTG GAACTGCGGA 1081 CAGGAAAACC TGGCATACAT GGGCGCGCAA TACGGGCCAT TTGATCAGCA CTTTGTGTAT 1141 GGTGATGGAG ATGGCCTTGA AGATGTCGTC AAAGCGTTCT CCTTTCTTCA AGGAAAGGAG 1201 TTCGAAGACA AAAAACTCAA CAAGCGTTCT GTAATGCCTC CGAAGTACGT GTTTGGTTTC 1261 TTCCAGGGTG TTTTCGGTGC ACTTTCACTG TTGAAGCAGA ATCTGCCTGC CGGAGAGAAC 1321 AACATCTCAG TGCAAGAGAT TGTGGAGGGT TACCAGGATA ACGACTACCC CTTTGAAGGG 1381 CTCGCGGTAG ATGTTGATAT GCAAGATGAT CTGCGAGTGT TTACTACCAA ACCAGAATAT 1*4*41 TGGTCGGCAA ACATGGTAGG CGAAGGCGGT GATCCTAATA ACAGATCAGT CTTTUAATGG 1501 GCACATGACA GGGGCCTTGT CTGTCAGACG AACGTAACTT GCTTCTTGAG GAACGATAAC 1561 AGTGGGAAAC CATACGAAGT GAATCAGACA TTGAGGGAGA AACAGTTGTA TACGAAGAAT 1621 GATTCCTTGA ACAACACCGA TTTTGGAACT ACCTCGGATG GGCCTGGCGA TGCGTACATT 1681 GGACATTTGG ACTATGGTGG TGGAGTGGAG TGTGATGCAA TCTTCCCAGA CTGGGGTCGA 17*41 CCAGACGTGG CTCAATGGTG GGGAGAAAAC TACAAGAAGC TGTTCAGCAT TGGTCTCGAT 1801 TTCGTGTGGC AGGATATGAC GGTACCTGCG ATGATGCCGC ACCGACTCGG TGATGCTGTC l86l AACAAAAATT CCGGTAGTTC GGCGCCGGGC TGGCCGAATG AGAACGATCC ATCCAACGGA 1921 CGATACAACT GGAAATCTTA TCATCCGCAA GTGCTCGTGA CCGACATGCG CTATGGTGCA 1981 GAGTATGGAA GGGAACCGAT GGTGTCTCAA CGCAACATTC ACGCCTACAC TCTTTGTGAA 20*41 TCTACCAGAC GGGAGGGAAT TGTGGGAAAC GCAGACAGTT TGACCAAGTT CCGCCGCAGT 2101 TACATCATCA GTCGAGGAGG TTACATCGGT AACCAGCATT TCGGAGGGAT GTGGGTTGGG 2161 GACAACAGTG CCACAGAATC CTACCTCCAA ATGATGTTGG CGAACATTAT CAACATGAAT 2221 ATGTCGTGCC TCCCGCTAGT TGGCTCTGAT ATTGGCGGGT TCACCCAGTA CAATGATGCG 2281 GGCGACCCAA CCCCCGAGGA TTTGATGGTA AGATTCGTGC AGGCTGGCTG TCTGCTACCG 23-41 TGGTTCAGAA ACCACTATGA CAGGTGGATT GAGTCCAAGA AGCACGGGAA GAAATACCAG 2*401 GAGTTATACA TGTACCCGGG GCAAAAGGAT ACGTTGAAGA AGTTCGTTGA ATTCCGCTAC 2*461 CGCTGGCAGG AGGTTTTGTA CACAGCCATG TACCAAAATG CTACCACTGG AGAGCCGATC 2521 ATCAAGGCGG CGCCCATGTA CAACAACGAC GTCAACGTGT ATAAATCGCA GAATGATCAT 2581 TTCCTTCTCG GTGGACATGA CGGCTATCGT ATTCTCTGCG CACCTGTTGT GCGCGAAAAT 2641 GCGACAAGTC GCGAAGTGTA CCTGCCTGTG TATAGCAAGT GGTTCAAATT CGGACCGGAC * 49 2701 TTTGACACTA AGCCCTTGGA AAATGAGATT CAAGGAGGTC AGACGCTTTA TAATTACGCT 2761 GCACCGCTGA ACGATTCGCC GATATTTGTG AGGGAAGGGA CTATTCTTCC GACACGGTAC 2821 ACGCTGGACG GTGTGAACAA ATCTATCAAC ACGTACACAG ACAATGATCC GCTTGTATTT 2881 GAGCTGTTCC CTCTCGAAAA CAACCAGGCG CATGGCTTGT TCTATCATGA TGATGGCGGT 29^1 GTCACCACCA ACGCTGAAGA CTTTGGCAAG TATTCTGTGA TCAGTGTGAA GGCCGCGCAG 3001 GAAGGTTCTC AAATGAGTGT CAAGTTTGAC AATGAAGTTT ATGAACACCA ATGGGGAGCA 3061 TCGTTCTATG TTCGTGTTCG TAATATGGGT GCTCCGTCTA ACATCAACGT ATCTTCTCAG 3121 ATTGGTCAAC AGGACATGCA ACAGAGCTCC GTGAGTTCCA GGGCGCAAAT GTTCΛCTAGT 3181 GCTAACGATG GCGAGTACTG GGTTGACCAG AGCACGAACT CGTTGTGGCT CAAGTTGCCT 3241 GGTGCAGTTA TCCAAGACGC TGCGATCACT GTTCGTTGA SEQ. ID. NO. 2 SEQUENCE TYPE: NUCLEIC ACID MOLECULE TYPE: DNA (GENOMIC) ORIGINAL SOURCE: ALGAL SEQUENCE LENGTH: 1712 BP STRANDEDNESS: DOUBLE SEQUENCE: 10 20 30 40 50 60 1 1 1 1 1 1 I I I I I I 1 ATGACAAACT ATAATTATGA CAATTTGAAC TACAATCAAC CGGACCTCAT CCCACCTGGC 61 CATGATTCAG ATCCTGACTA CTATATTCCG ATGTACTTTG CGGCACCATG GGTGATCGCA 121 CATGGATATC GTGGCACCAG CGACCAGTAC TCTTATGGAT GGTTTTTGGA CAATGTATCC l8l CAGTCCTACA CAAACACTGG CGATGATGCA TGGGCTGGTC AGAAGGATTT GGCGTACATG 241 GGGGCACAAT GTGGGCCTTT CGATCAACAT TTTGTGTATG AGGCTGGAGA TGGACTTGAA 301 GACGTTGTGA CCGCATTCTC TTATTTGCAA GGCAAGGAAT ATGAGAACCA GGGACTGAAT 361 ATACGTTCTG CAATGCCTCC GAAGTACGTT TTCGGATTTT TCCAAGGCGT ATTCGGAGCC 421 ACATCGCTGC TAAGGGACAA CTTACCTGCC GGCGAGAACA ACGTCTCTTT GGAAGAAATT 481 GTTGAAGGAT ATCAAAATCA GAACGTGCCA TTTGAAGGTC TTGCTGTGGA TGTTGATATG 5*41 CAAGATGACT TGAGAGTGTT CACTACGAGA CCAGCGTTTT GGACGGCAAA CAAGGTGGGG 601 GAAGGCGGTG ATCCAAACAA CAAGTCAGTG TTTGAGTGGG CACATGACAG GGGCCTTGTC 661 TGCCAGACGA ATGTAACTTG CTTCTTGAAG AACGAGAAAA ATCCTTACGA AGTGAATCAG 721 TCATTGAGGG AGAAGCAGTT GTATACGAAG AGTGATTCCT TGGACAACAT TGATTTTGGA 781 ACTACTCCAG ATGGGCCTAG CGATGCGTAC ATTGGACACT TAGACTACGG TGGTGGTGTG 841 GAGTGTGATG CACTATTCCC AGACTGGGGT CGACCAGACG TGGCTCAATG GTGGGGCGAT 901 AACTACAAGA AACTATTCAG CATTGGTCTC GATTTCGTCT GGCAAGATAT GACGGTACCT 961 GCGATGATGC CGCACCGACT CGGTGACCCT GTCGGCACAA ATTCCGGTGA GACGGCGCCG 1021 GGCTGGCCGA ATGATAAGGA TCCATCCAAC GGACGATACA ATTGGAAGTC TTACCATCCG 1081 CAAGTGCTCG TGACTGACAT GAGGTATGAC GATTACGGAA GAGATCCCAT TGTTACGCAA 1141 CGCAATCTCC ATGCCTACAC TCTTTGTGAG TCTACTAGGA GGGAAGGCAT TGTTGGAAAC 1201 GCAGATAGTC TGACGAAGTT CCGCCGCAGC TATATTATCA GTCGTGGAGG CTACATCGGT 1261 AATCAGCACT TTGGTGGGAT GTGGGTAGGA GACAACTCTT CTACGGAAGA CTACCTCGCA 1321 ATGATGGTTA TCAACGTTAT CAACATGAAC ATGTCCGGTG TCCCGCTCGT TGGTTCCGAT 1381 ATTGGAGGTT TCACGGAGCA TGACAAGAGA AACCCTTGCA CACCGGACTT GATGATGAGA 1441 TTTGTGCAGG CTGGATGCTT GCTACCGTGG TTCAGGAACC ACTACGATAG GTGGATCGAG 1501 AGCAAGAAAC ACGGAAAGAA CTACCAAGAG TTGTACATGT ACCGCGACCA CTTGGACGCC 1561 TTGAGAAGTT TTGTGGAACT CCGCTATCGC TGGCAGGAAG TGTTATACAC AGCCATGTAT 1621 CAGAATGCTT TGAACGGGAA GCCGATCATC AAAACGGTCT CCATGTACAA CAACGATATG l68l AACGTCAAAG ATGCTCAGAA TGACCACTTC CT SEQ. ID. NO. 3 SEQUENCE TYPE: ENZYME MOLECULE TYPE: AMINO ACID ORIGINAL SOURCE: ALGAL SEQUENCE LENGTH: 1092 AMINO ACIDS SEQUENCE: 5 10 15 I I I I I I 1 Met Phe Pro Thr Leu Thr Phe lie Ala Pro Ser Ala Leu Ala Ala 16 Ser Thr Phe Val Gly Ala Asp He Arg Ser Gly He Arg He Gin 31 Ser Ala Leu Pro Ala Val Arg Asn Ala Val Arg Arg Ser Lys His 46 Tyr Asn Val Ser Met Thr Ala Leu Ser Asp Lys Gin Thr Ala He 61 Ser He Gly Pro Asp Asn Pro Asp Gly He Asn Tyr Gin Asn Tyr 76 Asp Tyr He Pro Val Ala Gly Phe Thr Pro Leu Ser Asn Thr Asn 91 Trp Tyr Ala Ala Gly Ser Ser Thr Pro Gly Gly He Thr Asp Trp 106 Thr Ala Thr Met Asn Val Lys Phe Asp Arg He Asp Asn Pro Ser 121 Tyr Ser Asn Asn His Pro Val Gin He Gin Val Thr Ser Tyr Asn 136 Asn Asn Ser Phe Arg He Arg Phe Asn Pro Asp Gly Pro He Arg 151 Asp Val Ser Arg Gly Pro He Leu Lys Gin Gin Leu Thr Trp He 166 Arg Asn Gin Glu Leu Ala Gin Gly Cys Asn Pro Asn Met Ser Phe l8l Ser Pro Glu Gly Phe Leu Ser Phe Glu Thr Lys Asp Leu Asn Val 196 He He Tyr Gly Asn Cys Lys Met Arg Val Thr Lys Lys Asp Gly 211 Tyr Leu Val Met Glu Asn Asp Glu Cys Asn Ser Gin Ser Asp Gly 226 Asn Lys Cys Arg Gly Leu Met Tyr Val Asp Arg Leu Tyr Gly Asn 241 Ala He Ala Ser Val Gin Thr Asn Phe His Lys Asp Thr Ser Arg 256 Asn Glu Lys Phe Tyr Gly Ala Gly Glu Val Asn Cys Arg Tyr Glu 271 Glu Gin Gly Lys Ala Pro Thr Tyr Val Leu Glu Arg Ser Gly Leu 286 Ala Met Thr Asn Tyr Asn Tyr Asp Asn Leu Asn Tyr Asn Gin Pro 301 Asp Val Val Pro Pro Gly Tyr Pro Asp His Pro Asn Tyr Tyr He 316 Pro Met Tyr Tyr Ala Ala Pro Trp Leu Val Val Gin Gly Cys Ala 331 Gly Thr Ser Lys Gin Tyr Ser Tyr Gly Trp Phe Met Asp Asn Val 346 Ser Gin Ser Tyr Met Asn Thr Gly Asp Thr Ala Trp Asn Cys Gly 361 Gin Glu Asn Leu Ala Tyr Met Gly Ala Gin Tyr Gly Pro Phe Asp 376 Gin His Phe Val Tyr Gly Asp Gly Asp Gly Leu Glu Asp Val Val 391 Lys Ala Phe Ser Phe Leu Gin Gly Lys Glu Phe Glu Asp Lys Lys 406 Leu Asn Lys Arg Ser Val Met Pro Pro Lys Tyr Val Phe Gly Phe 421 Phe Gin Gly Val Phe Gly Ala Leu Ser Leu Leu Lys Gin Asn Leu 436 Pro Ala Gly Glu Asn Asn He Ser Val Gin Glu He Val Glu Gly 451 Tyr Gin Asp Asn Asp Tyr Pro Phe Glu Gly Leu Ala Val Asp Val 466 Asp Met Gin Asp Asp Leu Arg Val Phe Thr Thr Lys Pro Glu Tyr 481 Trp Ser Ala Asn Met Val Gly Glu Gly Gly Asp Pro Asn Asn Arg 496 Ser Val Phe Glu Trp Ala His Asp Arg Gly Leu Val Cys Gin Thr 511 Asn Val Thr Cys Phe Leu Arg Asn Asp Asn Ser Gly Lys Pro Tyr 526 Glu Val Asn Gin Thr Leu Arg Glu Lys Gin Leu Tyr Thr Lys Asn 541 Asp Ser Leu Asn Asn Thr Asp Phe Gly Thr Thr Ser Asp Gly Pro 556 Gly Asp Ala Tyr He Gly His Leu Asp Tyr Gly Gly Gly Val Glu 571 Cys Asp Ala He Phe Pro Asp Trp Gly Arg Pro Asp Val Ala Gin 586 Trp Trp Gly Glu Asn Tyr Lys Lys Leu Phe Ser He Gly Leu Asp 601 Phe Val Trp Gin Asp Met Thr Val Pro Ala Met Met Pro His Arg 6l6 Leu Gly Asp Ala Val Asn Lys Asn Ser Gly Ser Ser Ala Pro Gly 631 Trp Pro Asn Glu Asn Asp Pro Ser Asn Gly Arg Tyr Asn Trp Lys 646 Ser Tyr His Pro Gin Val Leu Val Thr Asp Met Arg Tyr Gly Ala 661 Glu Tyr Gly Arg Glu Pro Met Val Ser Gin Arg Asn He His Ala 676 Tyr Thr Leu Cys Glu Ser Thr Arg Arg Glu Gly He Val Gly Asn 691 Ala Asp Ser Leu Thr Lys Phe Arg Arg Ser Tyr He He Ser Arg 706 Gly Gly Tyr He Gly Asn Gin His Phe Gly Gly Met Trp Val Gly 721 Asp Asn Ser Ala Thr Glu Ser Tyr Leu Gin Met Met Leu Ala Asn 736 He He Asn Met Asn Met Ser Cys Leu Pro Leu Val Gly Ser Asp 751 He Gly Gly Phe Thr Gin Tyr Asn Asp Ala Gly Asp Pro Thr Pro 766 Glu Asp Leu Met Val Arg Phe Val Gin Ala Gly Cys Leu Leu Pro 78l Trp Phe Arg Asn His Tyr Asp Arg Trp He Glu Ser Lys Lys His 796 Gly Lys Lys Tyr Gin Glu Leu Tyr Met Tyr Pro Gly Gin Lys Asp 811 Thr Leu Lys Lys Phe Val Glu Phe Arg Tyr Arg Trp Gin Glu Val 826 Leu Tyr Thr Ala Met Tyr Gin Asn Ala Thr Thr Gly Glu Pro He 841 He Lys Ala Ala Pro Met Tyr Asn Asn Asp Val Asn Val Tyr Lys 856 Ser Gin Asn Asp His Phe Leu Leu Gly Gly His Asp Gly Tyr Arg 871 He Leu Cys Ala Pro Val Val Arg Glu Asn Ala Thr Ser Arg Glu 886 Val Tyr Leu Pro Val Tyr Ser Lys Trp Phe Lys Phe Gly Pro Asp 901 Phe Asp Thr Lys Pro Leu Glu Asn Glu He Gin Gly Gly Gin Thr 916 Leu Tyr Asn Tyr Ala Ala Pro Leu Asn Asp Ser Pro He Phe Val 931 Arg Glu Gly Thr He Leu Pro Thr Arg Tyr Thr Leu Asp Gly Val 946 Asn Lys Ser He Asn Thr Tyr Thr Asp Asn Asp Pro Leu Val Phe 961 Glu Leu Phe Pro Leu Glu Asn Asn Gin Ala His Gly Leu Phe Tyr 976 His Asp Asp Gly Gly Val Thr Thr Asn Ala Glu Asp Phe Gly Lys 991 Tyr Ser Val He Ser Val Lys Ala Ala Gin Glu Gly Ser Gin Met 1006 Ser Val Lys Phe Asp Asn Glu Val Tyr Glu His Gin Trp Gly Ala 1021 Ser Phe Tyr Val Arg Val Arg Asn Met Gly Ala Pro Ser Asn He 1036 Asn Val Ser Ser Gin He Gly Gin Gin Asp Met Gin Gin Ser Ser 1051 Val Ser Ser Arg Ala Gin Met Phe Thr Ser Ala Asn Asp Gly Glu 1066 Tyr Trp Val Asp Gin Ser Thr Asn Ser Leu Trp Leu Lys Leu Pro 1081 Gly Ala Val He Gin Asp Ala Ala He Thr Val Arg Number of amino acid residues: 1092 Amino acid composition (including the signal sequense) : 64 Ala 14 Cys l8 His 33 Met 56 Thr 48 Arg 55 Gin 45 He 49 Phe 22 Trp 89 Asn 49 Glu 65 Leu 9 Pro 67 Tyr 73 Asp 94 Gly 46 Lys 73 Ser 73 Val SEQ. ID. NO. 4 SEQUENCE TYPE: ENZYME MOLECULE TYPE: AMINO ACID ORIGINAL SOURCE: ALGAL SEQUENCE LENGTH: 570 AMINO ACIDS SEQUENCE: 5 10 15 I I I I I I 1 Met Thr Asn Tyr Asn Tyr Asp Asn Leu Asn Tyr Asn Gin Pro Asp 16 Leu He Pro Pro Gly His Asp Ser Asp Pro Asp Tyr Tyr He Pro 31 Met Tyr Phe Ala Ala Pro Trp Val He Ala His Gly Tyr Arg Gly 46 Thr Ser Asp Gin Tyr Ser Tyr Gly Trp Phe Leu Asp Asn Val Ser 61 Gin Ser Tyr Thr Asn Thr Gly Asp Asp Ala Trp Ala Gly Gin Lys 76 Asp Leu Ala Tyr Met Gly Ala Gin Cys Gly Pro Phe Asp Gin His 91 Phe Val Tyr Glu Ala Gly Asp Gly Leu Glu Asp Val Val Thr Ala 106 Phe Ser Tyr Leu Gin Gly Lys Glu Tyr Glu Asn Gin Gly Leu Asn 121 He Arg Ser Ala Met Pro Pro Lys Tyr Val Phe Gly Phe Phe Gin 136 Gly Val Phe Gly Ala Thr Ser Leu Leu Arg Asp Asn Leu Pro Ala 151 Gly Glu Asn Asn Val Ser Leu Glu Glu He Val Glu Gly Tyr Gin 166 Asn Gin Asn Val Pro Phe Glu Gly Leu Ala Val Asp Val Asp Met l8l Gin Asp Asp Leu Arg Val Phe Thr Thr Arg Pro Ala Phe Trp Thr 196 Ala Asn Lys Val Gly Glu Gly Gly Asp Pro Asn Asn Lys Ser Val 211 Phe Glu Trp Ala His Asp Arg Gly Leu Val Cys Gin Thr Asn Val 226 Thr Cys Phe Leu Lys Asn Glu Lys Asn Pro Tyr Glu Val Asn Gin 241 Ser Leu Arg Glu Lys Gin Leu Tyr Thr Lys Ser Asp Ser Leu Asp 256 Asn He Asp Phe Gly Thr Thr Pro Asp Gly Pro Ser Asp Ala Tyr 271 He Gly His Leu Asp Tyr Gly Gly Gly Val Glu Cys Asp Ala Leu 286 Phe Pro Asp Trp Gly Arg Pro Asp Val Ala Gin Trp Trp Gly Asp 301 Asn Tyr Lys Lys Leu Phe Ser He Gly Leu Asp Phe Val Trp Gin 316 Asp Met Thr Val Pro Ala Met Met Pro His Arg Leu Gly Asp Pro 331 Val Gly Thr Asn Ser Gly Glu Thr Ala Pro Gly Trp Pro Asn Asp 346 Lys Asp Pro Ser Asn Gly Arg Tyr Asn Trp Lys Ser Tyr His Pro 361 Gin Val Leu Val Thr Asp Met Arg Tyr Asp Asp Tyr Gly Arg Asp 376 Pro He Val Thr Gin Arg Asn Leu His Ala Tyr Thr Leu Cys Glu 391 Ser Thr Arg Arg Glu Gly He Val Gly Asn Ala Asp Ser Leu Thr 406 Lys Phe Arg Arg Ser Tyr He He Ser Arg Gly Gly Tyr He Gly 421 Asn Gin His Phe Gly Gly Met Trp Val Gly Asp Asn Ser Ser Thr 436 Glu Asp Tyr Leu Ala Met Met Val He Asn Val He Asn Met Asn 451 Met Ser Gly Val Pro Leu Val Gly Ser Asp He Gly Gly Phe Thr 466 Glu His Asp Lys Arg Asn Pro Cys Thr Pro Asp Leu Met Met Arg 481 Phe Val Gin Ala Gly Cys Leu Leu Pro Trp Phe Arg Asn His Tyr 496 Asp Arg Trp He Glu Ser Lys Lys His Gly Lys Asn Tyr Gin Glu 511 Leu Tyr Met Tyr Arg Asp His Leu Asp Ala Leu Arg Ser Phe Val 526 Glu Leu Arg Tyr Arg Trp Gin Glu Val Leu Tyr Thr Ala Met Tyr 541 Gin Asn Ala Leu Asn Gly Lys Pro He He Lys Thr Val Ser Met 55 Tyr Asn Asn Asp Met Asn Val Lys Asp Ala Gin Asn Asp His Phe I NDICATIONS RELATING TO A D EPOSITED MICROORGANISM (PCT Rule llbts) For receiving Office use only For International Bureau use only This sheet was received with the international application [ I This sheet was received by the International Bureau (AO) R.LR. PETHEB Authorized officer Authorized officer

Claims: 12026 57 £LΔIMS 1. An enzyme comprising at least any one of the amino acid sequences shown as SEQ. ID. No.s 3 - 4, or any variant thereof. 2. A nucleotide sequence coding for the enzyme of claim 1. 3. A nucleotide sequence according to claim 2 wherein the nucleotide sequence is a DNA sequence. 4. A nucleotide sequence comprising a sequence that is the same as, or is complementary to, or has substantial homology with, or contains any suitable codon substitutions for any of those of SEQ. ID. No. 1 or SEQ. ID. No. 2. 5. A method of preparing the sugar 1,5-D-anhydrofructose comprising treating an «-l,4-glucan with the enzyme α-l,4-glucan lyase, characterised in that enzyme is used in substantially pure form and wherein the enzyme is isolated from algae alone. 6. A method according to claim 5 wherein the algae is Gracilariopsis lemaneiformis. 7. A method according to claim 5 or claim 6 wherein the enzyme comprises at least any one of the amino acid sequences shown as SEQ. ID. No.s 3 - 4, or any variant thereof. 8. A method according to any preceding claim wherein the enzyme is obtained from the expression of a nucleotide sequence coding for the enzyme. 9. A method according to claim 8 wherein the nucleotide sequence is a DNA sequence. 10. A method according to claim 9 wherein the DNA sequence comprises a sequence that is the same as, or is complementary to, or has substantial homology with, or contains any suitable codon substitutions for any of those of SEQ. ID. No. 1 or SEQ. ID. No. 2. 11. A method according to any one of claims 5 - 10 wherein if the glucan contains links other than and in addition to the α-1,4- links the α-l,4-glucan lyase is used in conjunction with a suitable reagent that can break the other links. 12. A method according to any one of claims 5 - 11 wherein the glucan is starch and preferably a hydrolase, preferably a glucanohydrolase, is used in conjunction with the α-l,4-glucan lyase. 13. The method according to claim 12 wherein the starch is used in high concentration - such as up to about 25% solution. 14. A method according to claim 12 or claim 13 wherein the hydrolase is at least one of pullanase or isoamylase. 15. A method according to any one of claims 5 to 14 wherein the α-l,4-glucan lyase is bound to a support or, more preferably, is in a dissolved form. 16. A method according to claim 15 wherein the enzyme is isolated and/or further purified from algae alone using a gel that is not degraded by the enzyme. 17. A method according to claim 16 wherein the gel is based on dextrin or derivatives thereof, preferably the gel is a cyclodextrin - more preferably β- cyclodextrin. 18. The method according to any one of claims 5 to 17 wherein the substrate is treated with the enzyme in the presence of a buffer. 19. The method according to any one of claims 5 to 17 wherein the substrate is treated with the enzyme in the presence of at least substantially pure water. 20. The method according to any one of claims 5 to I V wherein the substrate is treated with the enzyme in the absence of a co-factor. 21. The method according to any one of claims 5 to 20 wherein the enzyme is used in combination with amylopectin or dextrin. 22. A method of preparing the sugar 1,5-D-anhydrofructose comprising treating an α-l,4-glucan with the enzyme α-l,4-glucan lyase characterised in that enzyme comprises at least any one of the amino acid sequences shown as SEQ. ID. No.s 3-4, or any variant thereof. 23. The sugar 1,5-D-anhydrofructose when prepared by the method of the present invention. 24. The use of a reagent that can increase the hydrophobicity of the reaction medium to increase the stability and actiyity of the GL enzyme. 25. Use of AF prepared by the method of the present invention as an anti-oxidant. 26. Use of AF prepared by the method of the present invention as a sweetener. RECTIFIED SHEET (RULE 91) ISA/EP

Inventors: BOJSEN KIRSTEN, MARCUSSEN JAN, YU SHUKUN, BOJSEN, KIRSTEN, MARCUSSEN, JAN, YU, SHUKUN
Applicants: BOJSEN KIRSTEN, DANISCO, MARCUSSEN JAN, YU SHUKUN, BOJSEN, KIRSTEN, DANISCO A/S, MARCUSSEN, JAN, YU, SHUKUN
Application year: 1995
Main classification: C12N15
IPC codes: C12N9